Clinical Trials Browser

Phase 1/2 × Terminated × Central Nervous System Neoplasms × Clear all

NCT03690869 2025-04-08

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Phase 1/2 Terminated

57 enrolled 31 charts

Diffuse Intrinsic Pontine Glioma, Glioma, Recurrence, Central Nervous System Neoplasms

NCT01295697 2022-02-14

Study of EZN-2208 Pediatric Patients With Solid Tumors

Phase 1/2 Terminated

Central Nervous System Neoplasms

NCT01582152 2019-06-05

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Phase 1/2 Terminated

12 enrolled 7 charts

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00021229 2014-07-31

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Phase 1/2 Terminated

85 enrolled 17 charts

Astrocytoma, Central Nervous System Neoplasms

NCT00107471 2013-12-10

Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma

Phase 1/2 Terminated

Brain Neoplasms, Central Nervous System Neoplasms

NCT00074334 2009-10-21

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Phase 1/2 Terminated

Familial ependymoma, Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms